Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7780]

EHA 2013: Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma

EHA 2013: Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma

$EHA 2013: Pomalidomide prolongs survival in refractory myeloma patients$

EHA 2013: Pomalidomide prolongs survival in refractory myeloma patients

Cancer Research UK collaborates with Abcodia for early diagnosis tests

Cancer Research UK collaborates with Abcodia for early diagnosis tests

ASCO 2013: Novel drug that inhibits Hsp90 effective as second-line therapy with docetaxel for advanced lung cancer

ASCO 2013: Novel drug that inhibits Hsp90 effective as second-line therapy with docetaxel for advanced lung cancer

ASCO 2013: Some patients with treatment-resistant colorectal cancers may have a new option

ASCO 2013: Some patients with treatment-resistant colorectal cancers may have a new option

ASCO 2013: Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer

ASCO 2013: Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer

ASCO 2013: Bevacizumab extends survival for relapsed and advanced cervical cancer

ASCO 2013: Bevacizumab extends survival for relapsed and advanced cervical cancer

ASCO 2013: Ten years of tamoxifen superior to five in reducing breast cancer recurrence and death

ASCO 2013: Ten years of tamoxifen superior to five in reducing breast cancer recurrence and death

ASCO 2013: Maintenance therapy with the multi-targeted drug pazopanib delays relapse of advanced ovarian cancer

ASCO 2013: Maintenance therapy with the multi-targeted drug pazopanib delays relapse of advanced ovarian cancer

ASCO completes electronic data sharing standard for breast cancer treatment

ASCO completes electronic data sharing standard for breast cancer treatment

More from ecancer